Trial NCT04039919

View at ClinicalTrials.gov 
Org. Study IDs: UP0071
Secondary IDs: 2019-000703-32

Last trial update was posted on 2021-06-18

MeSH Interventions

Padsevonil

MeSH Conditions


Other Conditions

Healthy Participants

Stopping Reasons

Based on available data, UCB has decided to stop development of padsevonil as adjunctive treatment of focal-onset seizures

Limitations And Caveats

The study was terminated because the decision was made to terminate the PSL development program in focal-onset seizures on 22 May 2020.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID